back
In the news
Pear Bio poster at ASCO 2022
15th of June 2022
Pear Bio has added immuno-oncology capabilities to our precision medicine platform. We can now track immune cell infiltration into patient-derived 3D tumor cultures using time-lapsed 3D microscopy.
See what we have in the works
Our drug discovery pipeline is focused on a range of indications from breast to lung cancer. Explore more about our pipeline.
Learn more